The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction.
Journal
European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
13
01
2023
accepted:
08
03
2023
medline:
26
6
2023
pubmed:
3
4
2023
entrez:
2
4
2023
Statut:
ppublish
Résumé
There are varied associations that have been identified between the use of androgen deprivation therapy (ADT) and the development of cognitive decline. We highlight the first studies to evaluate chronic use of ADT, other systemic treatments for prostate cancer, and genetic polymorphisms in this context.
Identifiants
pubmed: 37005166
pii: S2405-4569(23)00083-4
doi: 10.1016/j.euf.2023.03.015
pii:
doi:
Substances chimiques
Androgen Antagonists
0
Androgens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
409-410Informations de copyright
Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.